Conference Coverage

In abdominal myomectomy, cell salvage may reduce transfusions


 

REPORTING FROM SGS 2018


“If you take these 86 patients who had cell salvage intraoperatively, 14 of them ultimately required donor blood, and that amounted to 23 units, giving kind of a lower limit for the potential benefit of cell salvage in this patient cohort,” he said.

Abdominal myomectomy often has a high rate of blood loss, with about a 10%-20% rate of transfusion. While the technique of cell salvage is widely used in other fields, it hasn’t been fully investigated in the context of gynecologic surgery, he said, explaining the rationale for the study.

Subjects included were women aged 18-60 years who underwent abdominal myomectomy for benign indications at the Cleveland Clinic during 2011-2016. Those with current malignancy or with surgery performed by a gynecologic oncologist were excluded.

The non–cell salvage and cell salvage groups were comparable with respect to age, body mass index, ethnicity, and preoperative and postoperative hemoglobin.

Recommended Reading

Robotic-assisted pulmonary lobectomy effective for large tumors
MDedge Hematology and Oncology
Keep PCI patients on aspirin for noncardiac surgery
MDedge Hematology and Oncology
VIDEO: Dabigatran effective for myocardial injury after noncardiac surgery
MDedge Hematology and Oncology
VIDEO: Andexanet alfa effectively reverses factor Xa anticoagulant
MDedge Hematology and Oncology
FDA updates breast implant–associated lymphoma cases, risk
MDedge Hematology and Oncology
Study: No increased risk of serious AEs with combined urogyn/gyn onc surgery
MDedge Hematology and Oncology
VIDEO: Cervical cancer laparotomy outperforms minimally invasive surgery
MDedge Hematology and Oncology
What is HIPEC?
MDedge Hematology and Oncology
VTE risk after bariatric surgery should be assessed
MDedge Hematology and Oncology
FDA approves Doptelet for liver disease patients undergoing procedures
MDedge Hematology and Oncology